Nanotechnology in Medical Devices Market by Product (Biochip, Implant Materials, Medical Textiles, Wound Dressing, Cardiac Rhythm Management Devices, Hearing Aid), Application (Therapeutic, Diagnostic, Research) - Global Forecast to 2019
Over the last five years, the nanotechnology-based medical devices market witnessed tremendous growth primarily due to growth in the aging population, and increasing government support with increased nanotechnology R&D expenditure and increased international research collaborations.
In this report, the global nanotechnology-based medical devices market is segmented on the basis of products and applications. On the basis products, the nanotechnology-based medical devices market is categorized into biochips, implantable materials, medical textile and wound dressing, active implantable devices, and others. The implantable materials segment is bifurcated into dental filling materials and bone restorative materials; whereas, the active implantable devices segment is bifurcated into cardiac rhythm management devices, hearing aid devices, and retinal implants. On the basis of applications, the nanotechnology-based medical devices market is segmented into therapeutics applications, diagnostics applications, and research applications.
The global nanotechnology-based medical devices market is expected to grow at a significant CAGR of around 11-12% during the forecast period (2014–2019). The market is mainly driven by the growth in aging population, rising adoption of nanotechnology-based medical devices, and increased nanotechnology R&D expenditure. In addition, the governments of several nations are investing heavily in developing and commercializing new nanotechnology products. However, safety issues regarding nanotechnology-based medical devices, stringent regulatory guidelines, and time-consuming approval processes for these devices are hampering the growth of this market to a certain extent.
Active implantable devices accounted for a major share of the nanotechnology-based medical devices the market. The nanotechnology-based medical devices market for active implantable devices is primarily driven by the growing incidence of age-related disorders such as hearing and cardiovascular disorders. In addition, the growing awareness about these diseases and increased acceptance of the hearing aid devices are further driving the market for active implantable devices.
In 2013, North America accounted for the largest share to the global nanotechnology-based medical devices market, followed by Europe, Asia-Pacific, and RoW. However, Asia-Pacific is expected to be the fastest-growing region during the forecast period owing to the rapidly aging population, rising adoption of advanced nanotechnology-based medical devices, increased accessibility to healthcare facilities, and rising R&D and healthcare expenditure.
The global nanotechnology-based medical devices market is dominated by six players that accounted for around 65-70% of the global market in 2014. The major players in the global nanotechnology-based medical devices market are Stryker Corporation (U.S.), 3M Company (U.S.), St. Jude Medical, Inc. (U.S.), Affymetrix, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Starkey Hearing Technologies (U.S.), and Smith & Nephew plc (U.K.).
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater market share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping a greater market share.
This report provides insights on the following pointers:
In this report, the global nanotechnology-based medical devices market is segmented on the basis of products and applications. On the basis products, the nanotechnology-based medical devices market is categorized into biochips, implantable materials, medical textile and wound dressing, active implantable devices, and others. The implantable materials segment is bifurcated into dental filling materials and bone restorative materials; whereas, the active implantable devices segment is bifurcated into cardiac rhythm management devices, hearing aid devices, and retinal implants. On the basis of applications, the nanotechnology-based medical devices market is segmented into therapeutics applications, diagnostics applications, and research applications.
The global nanotechnology-based medical devices market is expected to grow at a significant CAGR of around 11-12% during the forecast period (2014–2019). The market is mainly driven by the growth in aging population, rising adoption of nanotechnology-based medical devices, and increased nanotechnology R&D expenditure. In addition, the governments of several nations are investing heavily in developing and commercializing new nanotechnology products. However, safety issues regarding nanotechnology-based medical devices, stringent regulatory guidelines, and time-consuming approval processes for these devices are hampering the growth of this market to a certain extent.
Active implantable devices accounted for a major share of the nanotechnology-based medical devices the market. The nanotechnology-based medical devices market for active implantable devices is primarily driven by the growing incidence of age-related disorders such as hearing and cardiovascular disorders. In addition, the growing awareness about these diseases and increased acceptance of the hearing aid devices are further driving the market for active implantable devices.
In 2013, North America accounted for the largest share to the global nanotechnology-based medical devices market, followed by Europe, Asia-Pacific, and RoW. However, Asia-Pacific is expected to be the fastest-growing region during the forecast period owing to the rapidly aging population, rising adoption of advanced nanotechnology-based medical devices, increased accessibility to healthcare facilities, and rising R&D and healthcare expenditure.
The global nanotechnology-based medical devices market is dominated by six players that accounted for around 65-70% of the global market in 2014. The major players in the global nanotechnology-based medical devices market are Stryker Corporation (U.S.), 3M Company (U.S.), St. Jude Medical, Inc. (U.S.), Affymetrix, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Starkey Hearing Technologies (U.S.), and Smith & Nephew plc (U.K.).
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater market share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping a greater market share.
This report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the nanotechnology-based medical devices market. The report analyzes the nanotechnology-based medical devices market by products and applications across all regions
- Product Development/Innovation: Detailed insights on upcoming trends, research and development activities, and new product launches in the nanotechnology-based medical devices market
- Market Development: Comprehensive information on the lucrative emerging markets by product, application, and region
- Market Diversification: Exhaustive information of new products, growing regions, recent developments, and investments in the nanotechnology-based medical devices market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of the leading players in the nanotechnology-based medical devices market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY AND PRICING
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 KEY DATA FROM SECONDARY SOURCES
2.6 KEY DATA FROM PRIMARY SOURCES
2.6.1 KEY INDUSTRY INSIGHTS
2.7 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 GROWTH POTENTIAL OF THE NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET
4.2 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET: GEOGRAPHIC MIX
4.3 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET IN ASIA-PACIFIC
4.1 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.2 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY APPLICATION: GEOGRAPHIC MIX
4.3 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET: DEVELOPING VS. DEVELOPED COUNTRIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET SEGMENTATION
5.2.1 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY TYPE
5.2.2 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY APPLICATION
5.3 KEY MARKET DYNAMICS
5.3.1 MARKET DRIVERS
5.3.1.1 Increasing government support
5.3.1.2 Growing geriatric population
5.3.2 MARKET RESTRAINTS
5.3.2.1 Stringent and time-consuming product approval processes
5.3.2.2 High prices of nanotechnology-based medical devices
5.3.3 MARKET OPPORTUNITIES
5.3.3.1 Rich mid-to-late stage product pipeline
5.3.3.2 High growth opportunities in emerging markets
5.3.4 MARKET CHALLENGES
5.3.4.1 Commercialization of nanotechnology-based devices
5.3.4.2 Inadequate standards and lack of regulatory approval frameworks
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 VALUE CHAIN ANALYSIS
6.3 INDUSTRY TRENDS
6.3.1 INCREASING TREND TOWARDS INTERNATIONAL COLLABORATIONS
6.3.2 RISING NUMBER OF PUBLIC-PRIVATE PARTNERSHIPS
6.4 PORTER’S FIVE FORCES ANALYSIS
6.4.1 THREAT OF NEW ENTRANTS
6.4.2 THREAT OF SUBSTITUTES
6.4.3 BARGAINING POWER OF SUPPLIERS
6.4.4 BARGAINING POWER OF BUYERS
6.4.5 INTENSITY OF COMPETITIVE RIVALRY
7 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY PRODUCT
7.1 INTRODUCTION
7.2 ACTIVE IMPLANTable DEVICES
7.2.1 CARDIAC RHYTHM MANAGEMENT DEVICES
7.2.2 HEARING AID DEVICES
7.2.3 RETINAL IMPLANTS
7.3 BIOCHIPS
7.3.1 DNA MICROARRAYS
7.3.2 LAB-ON-A-CHIP
7.4 IMPLANTable MATERIALS
7.4.1 BONE SUBSTITUTE MATERIALS
7.4.2 DENTAL RESTORATIVE MATERIALS
7.5 MEDICAL TEXTILES AND WOUND DRESSINGS
7.6 OTHERS
8 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 THERAPEUTIC APPLICATIONS
8.3 RESEARCH APPLICATIONS
8.4 DIAGNOSTIC APPLICATIONS
9 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 FRANCE
9.3.3 U.K.
9.3.4 ITALY
9.3.5 SPAIN
9.3.6 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 JAPAN
9.4.2 CHINA
9.4.3 INDIA
9.4.4 REST OF ASIA-PACIFIC
9.5 REST OF THE WORLD (ROW)
9.5.1 LATIN AMERICA
9.5.2 MIDDLE EAST AND AFRICA
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 MARKET SHARE ANALYSIS
10.3 COMPETITIVE SITUATION AND TRENDS
10.4 NEW PRODUCT LAUNCHES
10.5 MERGERS AND ACQUISITIONS
10.6 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
10.7 OTHERS
11 COMPANY PROFILES (OVERVIEW, FINANCIALS, PRODUCTS & SERVICES, STRATEGY, & DEVELOPMENTS)
11.1 INTRODUCTION
11.2 ST. JUDE MEDICAL, INC.
11.3 PERKINELMER, INC.
11.4 STARKEY HEARING TECHNOLOGIES
11.5 STRYKER CORPORATION
11.6 AFFYMETRIX, INC.
11.7 3M COMPANY
11.8 SMITH & NEPHEW PLC
11.9 MITSUI CHEMICALS, INC.
11.10 DENTSPLY INTERNATIONAL
11.11 AAP IMPLANTATE AG (Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.)
12 APPENDIX
12.1 INSIGHTS OF INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 AVAILABLE CUSTOMIZATIONS
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 RELATED REPORTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY AND PRICING
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 KEY DATA FROM SECONDARY SOURCES
2.6 KEY DATA FROM PRIMARY SOURCES
2.6.1 KEY INDUSTRY INSIGHTS
2.7 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 GROWTH POTENTIAL OF THE NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET
4.2 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET: GEOGRAPHIC MIX
4.3 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET IN ASIA-PACIFIC
4.1 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.2 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY APPLICATION: GEOGRAPHIC MIX
4.3 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET: DEVELOPING VS. DEVELOPED COUNTRIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET SEGMENTATION
5.2.1 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY TYPE
5.2.2 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY APPLICATION
5.3 KEY MARKET DYNAMICS
5.3.1 MARKET DRIVERS
5.3.1.1 Increasing government support
5.3.1.2 Growing geriatric population
5.3.2 MARKET RESTRAINTS
5.3.2.1 Stringent and time-consuming product approval processes
5.3.2.2 High prices of nanotechnology-based medical devices
5.3.3 MARKET OPPORTUNITIES
5.3.3.1 Rich mid-to-late stage product pipeline
5.3.3.2 High growth opportunities in emerging markets
5.3.4 MARKET CHALLENGES
5.3.4.1 Commercialization of nanotechnology-based devices
5.3.4.2 Inadequate standards and lack of regulatory approval frameworks
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 VALUE CHAIN ANALYSIS
6.3 INDUSTRY TRENDS
6.3.1 INCREASING TREND TOWARDS INTERNATIONAL COLLABORATIONS
6.3.2 RISING NUMBER OF PUBLIC-PRIVATE PARTNERSHIPS
6.4 PORTER’S FIVE FORCES ANALYSIS
6.4.1 THREAT OF NEW ENTRANTS
6.4.2 THREAT OF SUBSTITUTES
6.4.3 BARGAINING POWER OF SUPPLIERS
6.4.4 BARGAINING POWER OF BUYERS
6.4.5 INTENSITY OF COMPETITIVE RIVALRY
7 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY PRODUCT
7.1 INTRODUCTION
7.2 ACTIVE IMPLANTable DEVICES
7.2.1 CARDIAC RHYTHM MANAGEMENT DEVICES
7.2.2 HEARING AID DEVICES
7.2.3 RETINAL IMPLANTS
7.3 BIOCHIPS
7.3.1 DNA MICROARRAYS
7.3.2 LAB-ON-A-CHIP
7.4 IMPLANTable MATERIALS
7.4.1 BONE SUBSTITUTE MATERIALS
7.4.2 DENTAL RESTORATIVE MATERIALS
7.5 MEDICAL TEXTILES AND WOUND DRESSINGS
7.6 OTHERS
8 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 THERAPEUTIC APPLICATIONS
8.3 RESEARCH APPLICATIONS
8.4 DIAGNOSTIC APPLICATIONS
9 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 FRANCE
9.3.3 U.K.
9.3.4 ITALY
9.3.5 SPAIN
9.3.6 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 JAPAN
9.4.2 CHINA
9.4.3 INDIA
9.4.4 REST OF ASIA-PACIFIC
9.5 REST OF THE WORLD (ROW)
9.5.1 LATIN AMERICA
9.5.2 MIDDLE EAST AND AFRICA
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 MARKET SHARE ANALYSIS
10.3 COMPETITIVE SITUATION AND TRENDS
10.4 NEW PRODUCT LAUNCHES
10.5 MERGERS AND ACQUISITIONS
10.6 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
10.7 OTHERS
11 COMPANY PROFILES (OVERVIEW, FINANCIALS, PRODUCTS & SERVICES, STRATEGY, & DEVELOPMENTS)
11.1 INTRODUCTION
11.2 ST. JUDE MEDICAL, INC.
11.3 PERKINELMER, INC.
11.4 STARKEY HEARING TECHNOLOGIES
11.5 STRYKER CORPORATION
11.6 AFFYMETRIX, INC.
11.7 3M COMPANY
11.8 SMITH & NEPHEW PLC
11.9 MITSUI CHEMICALS, INC.
11.10 DENTSPLY INTERNATIONAL
11.11 AAP IMPLANTATE AG (Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.)
12 APPENDIX
12.1 INSIGHTS OF INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 AVAILABLE CUSTOMIZATIONS
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 RELATED REPORTS
LIST OF TABLES
Table 1 INCREASING GOVERNMENT SUPPORT FUELING GROWTH OF THE NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET
Table 2 STRINGENT PRODUCT APPROVAL PROCESSES HINDERING THE GROWTH OF NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET
Table 3 COMMERCIALIZATION OF NANOTECHNOLOGY-BASED DEVICES PRESENT A MAJOR CHALLENGE FOR THE GROWTH OF NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET
Table 4 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 5 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 6 GLOBAL NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 7 GLOBAL NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 8 GLOBAL NANOTECHNOLOGY-BASED CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 9 GLOBAL NANOTECHNOLOGY-BASED HEARING AID DEVICES MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 10 GLOBAL NANOTECHNOLOGY-BASED RETINAL IMPLANTS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 11 GLOBAL NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 12 GLOBAL NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 13 GLOBAL NANOTECHNOLOGY-BASED DNA MICROARRAYS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 14 GLOBAL NANOTECHNOLOGY-BASED LAB-ON-CHIPS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 15 GLOBAL NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 16 GLOBAL NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 17 GLOBAL NANOTECHNOLOGY-BASED BONE SUBSTITUTE MATERIALS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 18 GLOBAL NANOTECHNOLOGY-BASED DENTAL RESTORATIVE MATERIALS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 19 GLOBAL NANOTECHNOLOGY-BASED MEDICAL TEXTILES AND WOUND DRESSINGS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 20 GLOBAL OTHER NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 21 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 22 GLOBAL NANOTEHCNOLOGY-BASED MEDICAL DEVICES MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 23 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE FOR RESEARCH APPLICATIONS, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 24 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE FOR DIAGNOSTIC APPLICATIONS, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 25 NORTH AMERICA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
Table 26 NORTH AMERICA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 27 NORTH AMERICA: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 28 NORTH AMERICA: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 29 NORTH AMERICA: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 30 NORTH AMERICA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 31 U.S.: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 32 U.S.: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 33 U.S.: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 34 U.S.: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 35 U.S.: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 36 CANADA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 37 CANADA: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 38 CANADA: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 39 CANADA: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 40 EUROPE: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY COUNTRY/REGION, 2012–2019 ($MILLION)
Table 41 EUROPE: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 42 EUROPE: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 43 EUROPE: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 44 EUROPE: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 45 EUROPE: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 46 GERMANY: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 47 GERMANY: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 48 GERMANY: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 49 GERMANY: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 50 GERMANY: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 51 FRANCE: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 52 FRANCE: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 53 FRANCE: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 54 FRANCE: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 55 FRANCE: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 56 U.K.: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 57 U.K.: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 58 U.K.: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 59 U.K.: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 60 U.K.: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 61 ITALY: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 62 ITALY: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 63 ITALY: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 64 ITALY: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 65 ITALY: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 66 SPAIN: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 67 SPAIN: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 68 SPAIN: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 69 SPAIN: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 70 SPAIN: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 71 REST OF EUROPE: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 72 REST OF EUROPE: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 73 REST OF EUROPE: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 74 REST OF EUROPE: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 75 REST OF EUROPE: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 76 ASIA-PACIFIC: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY COUNTRY/REGION, 2012–2019 ($MILLION)
Table 77 ASIA-PACIFIC: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 78 ASIA-PACIFIC: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 79 ASIA-PACIFIC: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 80 ASIA-PACIFIC: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 81 ASIA-PACIFIC: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 82 JAPAN: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 83 JAPAN: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 84 JAPAN: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 85 JAPAN: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 86 JAPAN: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 87 CHINA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 88 CHINA: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 89 CHINA: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 90 CHINA: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 91 CHINA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 92 INDIA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 93 INDIA: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 94 INDIA: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 95 INDIA: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 96 INDIA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 97 ROAPAC: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 98 ROAPAC: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 99 ROAPAC: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 100 ROAPAC: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 101 ROAPAC: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 102 ROW: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
Table 103 ROW: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 104 ROW: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 105 ROW: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 106 ROW: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 107 ROW: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 108 LATIN AMERICA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 109 LATIN AMERICA: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 110 LATIN AMERICA: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 111 LATIN AMERICA: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 112 LATIN AMERICA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 113 MIDDLE EAST AND AFRICA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 114 MIDDLE EAST AND AFRICA: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 115 MIDDLE EAST AND AFRICA: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 116 MIDDLE EAST AND AFRICA: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 117 MIDDLE EAST AND AFRICA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 118 RECENT DEVELOPMENTS, 2011–2015
Table 119 RECENT DEVELOPMENTS, 2011–2014
Table 120 RECENT DEVELOPMENTS, 2011–2014
Table 121 RECENT DEVELOPMENTS, 2011–2014
Table 1 INCREASING GOVERNMENT SUPPORT FUELING GROWTH OF THE NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET
Table 2 STRINGENT PRODUCT APPROVAL PROCESSES HINDERING THE GROWTH OF NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET
Table 3 COMMERCIALIZATION OF NANOTECHNOLOGY-BASED DEVICES PRESENT A MAJOR CHALLENGE FOR THE GROWTH OF NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET
Table 4 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 5 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 6 GLOBAL NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 7 GLOBAL NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 8 GLOBAL NANOTECHNOLOGY-BASED CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 9 GLOBAL NANOTECHNOLOGY-BASED HEARING AID DEVICES MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 10 GLOBAL NANOTECHNOLOGY-BASED RETINAL IMPLANTS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 11 GLOBAL NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 12 GLOBAL NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 13 GLOBAL NANOTECHNOLOGY-BASED DNA MICROARRAYS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 14 GLOBAL NANOTECHNOLOGY-BASED LAB-ON-CHIPS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 15 GLOBAL NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 16 GLOBAL NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 17 GLOBAL NANOTECHNOLOGY-BASED BONE SUBSTITUTE MATERIALS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 18 GLOBAL NANOTECHNOLOGY-BASED DENTAL RESTORATIVE MATERIALS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 19 GLOBAL NANOTECHNOLOGY-BASED MEDICAL TEXTILES AND WOUND DRESSINGS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 20 GLOBAL OTHER NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 21 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 22 GLOBAL NANOTEHCNOLOGY-BASED MEDICAL DEVICES MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 23 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE FOR RESEARCH APPLICATIONS, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 24 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE FOR DIAGNOSTIC APPLICATIONS, BY GEOGRAPHY, 2012–2019 ($MILLION)
Table 25 NORTH AMERICA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
Table 26 NORTH AMERICA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 27 NORTH AMERICA: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 28 NORTH AMERICA: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 29 NORTH AMERICA: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 30 NORTH AMERICA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 31 U.S.: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 32 U.S.: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 33 U.S.: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 34 U.S.: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 35 U.S.: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 36 CANADA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 37 CANADA: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 38 CANADA: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 39 CANADA: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 40 EUROPE: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY COUNTRY/REGION, 2012–2019 ($MILLION)
Table 41 EUROPE: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 42 EUROPE: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 43 EUROPE: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 44 EUROPE: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 45 EUROPE: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 46 GERMANY: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 47 GERMANY: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 48 GERMANY: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 49 GERMANY: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 50 GERMANY: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 51 FRANCE: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 52 FRANCE: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 53 FRANCE: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 54 FRANCE: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 55 FRANCE: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 56 U.K.: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 57 U.K.: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 58 U.K.: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 59 U.K.: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 60 U.K.: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 61 ITALY: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 62 ITALY: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 63 ITALY: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 64 ITALY: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 65 ITALY: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 66 SPAIN: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 67 SPAIN: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 68 SPAIN: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 69 SPAIN: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 70 SPAIN: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 71 REST OF EUROPE: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 72 REST OF EUROPE: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 73 REST OF EUROPE: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 74 REST OF EUROPE: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 75 REST OF EUROPE: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 76 ASIA-PACIFIC: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY COUNTRY/REGION, 2012–2019 ($MILLION)
Table 77 ASIA-PACIFIC: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 78 ASIA-PACIFIC: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 79 ASIA-PACIFIC: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 80 ASIA-PACIFIC: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 81 ASIA-PACIFIC: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 82 JAPAN: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 83 JAPAN: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 84 JAPAN: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 85 JAPAN: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 86 JAPAN: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 87 CHINA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 88 CHINA: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 89 CHINA: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 90 CHINA: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 91 CHINA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 92 INDIA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 93 INDIA: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 94 INDIA: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 95 INDIA: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 96 INDIA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 97 ROAPAC: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 98 ROAPAC: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 99 ROAPAC: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 100 ROAPAC: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 101 ROAPAC: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 102 ROW: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
Table 103 ROW: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 104 ROW: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 105 ROW: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 106 ROW: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 107 ROW: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 108 LATIN AMERICA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 109 LATIN AMERICA: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 110 LATIN AMERICA: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 111 LATIN AMERICA: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 112 LATIN AMERICA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 113 MIDDLE EAST AND AFRICA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 114 MIDDLE EAST AND AFRICA: NANOTECHNOLOGY-BASED ACTIVE IMPLANTable DEVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 115 MIDDLE EAST AND AFRICA: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 116 MIDDLE EAST AND AFRICA: NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
Table 117 MIDDLE EAST AND AFRICA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
Table 118 RECENT DEVELOPMENTS, 2011–2015
Table 119 RECENT DEVELOPMENTS, 2011–2014
Table 120 RECENT DEVELOPMENTS, 2011–2014
Table 121 RECENT DEVELOPMENTS, 2011–2014
LIST OF FIGURES
Figure 1 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY TYPE
Figure 2 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY APPLICATION
Figure 3 RESEARCH DESIGN
Figure 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 5 BOTTOM-UP APPROACH
Figure 6 TOP-DOWN APPROACH
Figure 7 DATA TRIANGULATION METHODOLOGY
Figure 8 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY PRODUCT, 2014 VS. 2019 ($MILLION)
Figure 9 GLOBAL NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET, BY TYPE, 2014 VS. 2019 ($MILLION)
Figure 10 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY APPLICATION, 2014 VS. 2019 ($MILLION)
Figure 11 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2014 VS. 2019 ($MILLION)
Figure 12 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SHARE, 2014
Figure 13 RISING AGING POPULATION AND GOVERNMENT SUPPORT TO DRIVE MARKET GROWTH
Figure 14 NORTH AMERICA WILL CONTINUE TO DOMINATE THE NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET BY 2019
Figure 15 THERAPEUTIC APPLICATIONS SEGMENT COMMANDED THE LARGEST SHARE OF THE APAC MARKET
Figure 16 U.S. COMMANDED LION'S SHARE OF THE GLOBAL MARKET IN 2014
Figure 17 NORTH AMERICA DOMINATED THE THERAPEUTIC APPLICATIONS MARKET IN 2014
Figure 18 DEVELOPING MARKETS TO REGISTER HIGH GROWTH DURING THE FORECAST PERIOD
Figure 19 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SEGMENTATION, BY TYPE
Figure 20 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SEGMENTATION, BY APPLICATION
Figure 21 INCREASING GOVERNMENT SUPPORT TO SPUR THE DEMAND FOR NANOTECHNOLOGY-BASED MEDICAL DEVICES
Figure 22 DEMOGRAPHIC GROWTH TRENDS OF THE ELDERLY POPULATION
Figure 23 VALUE CHAIN ANALYSIS
Figure 24 RISING NUMBER OF TRANSNATIONAL AND PUBLIC-PRIVATE COLLABORATIONS TO SHAPE MARKET GROWTH
Figure 25 MASSIVE GROWTH POTENTIAL IN THE NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET ENHANCING COMPETITION AMONG MARKET PLAYERS
Figure 26 ACTIVE IMPLANTable DEVICES DOMINATE THE GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET
Figure 27 ASIA-PACIFIC IS THE MOST LUCRATIVE MARKET FOR ACTIVE IMPLANTable DEVICES
Figure 28 APAC TO REGISTER MAXIMUM GROWTH IN THE FORECAST PERIOD
Figure 29 GLOBAL NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET, BY TYPE 2014 VS. 2019
Figure 30 THERAPEUTIC APPLICATIONS COMMANDED LARGEST SHARE OF THE NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET IN 2014
Figure 31 APAC TO WITNESS HIGHEST GROWTH IN FORECAST PERIOD
Figure 32 GEOGRAPHICAL SNAPSHOT (2014–2019) – EMERGING MARKETS IN APAC REGION ARE EMERGING AS NEW HOT SPOTS
Figure 33 JAPAN OFFERS HIGHEST GROWTH POTENTIAL IN ALMOST ALL THE MARKETS
Figure 34 NORTH AMERICA NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SNAPSHOT: GROWTH WILL BE DRIVEN BY GROWING AGING POPULATION
Figure 35 ASIA-PACIFIC NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SNAPSHOT: GROWTH WILL BE DRIVEN BY RAPID DEVELOPMENT OF HEALTHCARE INDUSTRY
Figure 36 NEW PRODUCT LAUNCHES WAS THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS OVER THE LAST FOUR YEARS (2011-2014)
Figure 37 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
Figure 38 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY
Figure 39 GEOGRAPHY REVENUE MIX OF TOP MARKET PLAYERS
Figure 40 ST. JUDE MEDICAL, INC.: COMPANY SNAPSHOT
Figure 41 PERKINELMER, INC.: COMPANY SNAPSHOT
Figure 42 STRYKER CORPORATION: COMPANY SNAPSHOT
Figure 43 AFFYMETRIX, INC.: COMPANY SNAPSHOT
Figure 44 3M COMPANY: COMPANY SNAPSHOT
Figure 45 SMITH & NEPHEW PLC: COMPANY SNAPSHOT
Figure 46 MITSUI CHEMICALS, INC.: COMPANY SNAPSHOT
Figure 47 DENTSPLY INTERNATIONAL: COMPANY SNAPSHOT
Figure 48 AAP IMPLANTATE AG: COMPANY SNAPSHOT
Figure 1 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY TYPE
Figure 2 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY APPLICATION
Figure 3 RESEARCH DESIGN
Figure 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 5 BOTTOM-UP APPROACH
Figure 6 TOP-DOWN APPROACH
Figure 7 DATA TRIANGULATION METHODOLOGY
Figure 8 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY PRODUCT, 2014 VS. 2019 ($MILLION)
Figure 9 GLOBAL NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET, BY TYPE, 2014 VS. 2019 ($MILLION)
Figure 10 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY APPLICATION, 2014 VS. 2019 ($MILLION)
Figure 11 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2014 VS. 2019 ($MILLION)
Figure 12 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SHARE, 2014
Figure 13 RISING AGING POPULATION AND GOVERNMENT SUPPORT TO DRIVE MARKET GROWTH
Figure 14 NORTH AMERICA WILL CONTINUE TO DOMINATE THE NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET BY 2019
Figure 15 THERAPEUTIC APPLICATIONS SEGMENT COMMANDED THE LARGEST SHARE OF THE APAC MARKET
Figure 16 U.S. COMMANDED LION'S SHARE OF THE GLOBAL MARKET IN 2014
Figure 17 NORTH AMERICA DOMINATED THE THERAPEUTIC APPLICATIONS MARKET IN 2014
Figure 18 DEVELOPING MARKETS TO REGISTER HIGH GROWTH DURING THE FORECAST PERIOD
Figure 19 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SEGMENTATION, BY TYPE
Figure 20 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SEGMENTATION, BY APPLICATION
Figure 21 INCREASING GOVERNMENT SUPPORT TO SPUR THE DEMAND FOR NANOTECHNOLOGY-BASED MEDICAL DEVICES
Figure 22 DEMOGRAPHIC GROWTH TRENDS OF THE ELDERLY POPULATION
Figure 23 VALUE CHAIN ANALYSIS
Figure 24 RISING NUMBER OF TRANSNATIONAL AND PUBLIC-PRIVATE COLLABORATIONS TO SHAPE MARKET GROWTH
Figure 25 MASSIVE GROWTH POTENTIAL IN THE NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET ENHANCING COMPETITION AMONG MARKET PLAYERS
Figure 26 ACTIVE IMPLANTable DEVICES DOMINATE THE GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET
Figure 27 ASIA-PACIFIC IS THE MOST LUCRATIVE MARKET FOR ACTIVE IMPLANTable DEVICES
Figure 28 APAC TO REGISTER MAXIMUM GROWTH IN THE FORECAST PERIOD
Figure 29 GLOBAL NANOTECHNOLOGY-BASED IMPLANTable MATERIALS MARKET, BY TYPE 2014 VS. 2019
Figure 30 THERAPEUTIC APPLICATIONS COMMANDED LARGEST SHARE OF THE NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET IN 2014
Figure 31 APAC TO WITNESS HIGHEST GROWTH IN FORECAST PERIOD
Figure 32 GEOGRAPHICAL SNAPSHOT (2014–2019) – EMERGING MARKETS IN APAC REGION ARE EMERGING AS NEW HOT SPOTS
Figure 33 JAPAN OFFERS HIGHEST GROWTH POTENTIAL IN ALMOST ALL THE MARKETS
Figure 34 NORTH AMERICA NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SNAPSHOT: GROWTH WILL BE DRIVEN BY GROWING AGING POPULATION
Figure 35 ASIA-PACIFIC NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SNAPSHOT: GROWTH WILL BE DRIVEN BY RAPID DEVELOPMENT OF HEALTHCARE INDUSTRY
Figure 36 NEW PRODUCT LAUNCHES WAS THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS OVER THE LAST FOUR YEARS (2011-2014)
Figure 37 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
Figure 38 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY
Figure 39 GEOGRAPHY REVENUE MIX OF TOP MARKET PLAYERS
Figure 40 ST. JUDE MEDICAL, INC.: COMPANY SNAPSHOT
Figure 41 PERKINELMER, INC.: COMPANY SNAPSHOT
Figure 42 STRYKER CORPORATION: COMPANY SNAPSHOT
Figure 43 AFFYMETRIX, INC.: COMPANY SNAPSHOT
Figure 44 3M COMPANY: COMPANY SNAPSHOT
Figure 45 SMITH & NEPHEW PLC: COMPANY SNAPSHOT
Figure 46 MITSUI CHEMICALS, INC.: COMPANY SNAPSHOT
Figure 47 DENTSPLY INTERNATIONAL: COMPANY SNAPSHOT
Figure 48 AAP IMPLANTATE AG: COMPANY SNAPSHOT
